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study question: Does ulipristal acetate (UPA), a selective progesterone receptor modulator used for emergency contraception (EC),
interfere with fertilization or early embryo development in vitro and in vivo?
summary answer: At doses similar to those used for EC, UPA does not affect mouse gamete transport, fertilization or embryo devel-
opment.
what is known already: UPA acts as an emergency contraceptive mainly by inhibiting or delaying ovulation. However, there is little
information regarding its effects on post-ovulatory events preceding implantation.
study design, size, duration: This was an in vitro and in vivo experimental study involving the use of mouse gametes and embryos
from at least three animals in each set of experiments.
participants/materials, setting, methods: For in vitro fertilization experiments, mouse epididymal spermatozoa capacitated
in the presence of different concentrations of UPA (0–1000 ng/ml) were used to inseminate cumulus-intact or cumulus-free eggs in the presence or
absence of UPA during gamete co-incubation, and the percentage of fertilized eggs was determined. For in vivo fertilization experiments, superovu-
lated females caged with proven fertile males were injected with UPA (40 mg/kg) or vehicle just before or just after mating and the percentage of
fertilized eggs recovered from the ampulla was determined. To investigate the effect of UPA on embryo development, zygotes were recovered
from mated females, cultured in the presence of UPA (1000 ng/ml) for 4 days and the progression of embryo development was monitored daily.
main results and the role of chance: In vitro studies revealed that the presence of UPA during capacitation and/or gamete co-
incubation does not affect fertilization. Whereas the in vivo administration of UPA at the same time as hCG injection produced a decrease in the
number of eggs ovulated compared with controls (vehicle injected animals, P , 0.05), no effects on fertilization were observed when UPAwas admi-
nistered shortly before or after mating. No differences were observed in either the percentage of cleaved embryos or the cleavage speed when UPA
was present during in vitro embryo culture.
limitations, reasons for caution: Considering the ethical and technical limitations inherent to the use of human gametes for fer-
tilization studies, the mouse model was used as an approach for exploring the potential effects of UPA on in vivo sperm transport and fertilization.
Nevertheless, the extrapolation of these results to humans requires further investigation.
wider implications of the findings: This study presents new evidence on the lack of effect of UPA on gamete interaction and
embryo development, providing new insights into the mechanism of action of UPA as an emergency contraceptive method with potential clinical
implications. These new findings could contribute to increase the acceptability and proper use of UPA as an emergency contraceptive method.
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Emergency contraception (EC) is an important back-up method in cases
of unprotected intercourse or failure of a regular contraceptive method.
The efficacy of emergency contraceptive pills depends on several factors
including how and when they are used and their mechanism of action. An
ideal emergency contraceptive method should be safe and acceptable,
readily available and act through mechanisms that make it effective
during theentire fertilewindow (Gemzell-Danielsson and Trussell, 2013).
Progesterone (P) is a key modulator of normal female reproductive
functions and its actions are required for ovulation as well as for providing
an appropriate uterine environment for maintenance of pregnancy
(Niswender et al., 2000; Wira et al., 2015). These biological effects of
P are mediated by modulation of the transcriptional activity of two spe-
cific intracellular P receptors (PRs) termed PR-A and PR-B (Mulac-
Jericevic and Conneely, 2004). In addition, it has been reported that P
also facilitates sperm-egg interaction within the female genital tract in
several species (Libersky and Boatman, 1995; Holt and Fazeli, 2010)
through the regulation of different sperm capacitation-associated pro-
cesses. In this regard, it has been shown that in spermatozoa, P is able
to induce calcium influx (Blackmore et al., 1990, 1991; Lishko et al.,
2011; Strunker et al., 2011), protein tyrosine phosphorylation (Chung
et al., 2014) and other signalling cascades thatend in the occurrence acro-
some reaction, hyperactivation and chemotaxis (Uhleret al., 1992; Teves
et al., 2006; Baldi et al., 2009; Sagare-Patil et al., 2012). As spermatozoa
are transcriptionally silent cells, all these effects are most likely mediated
through non-genomic membrane P receptor/s whose identity and local-
ization have not yet been completely elucidated.
Considering the importance of P in the fertilization process, synthetic
compounds ranging from pure antagonists to a mixture of agonistic/
antagonistic actions on nuclear PR have been developed with applica-
tions in contraception. Ulipristal acetate (UPA; 17-alpha-acetoxy-11-
beta-[4-N,N-dimethylaminophenyl]-19-norpregna-4,9-diene-3,20-dione;
derivative of 19-norprogesterone) is a selective PR modulator, which has
been introduced into the market as an emergency contraceptive pill
in different countries. UPA binds with high affinity to both PR-A and
PR-B isoforms exhibiting mixed agonistic/antagonistic properties
(Blithe et al., 2003; Chabbert-Buffet et al., 2005; Gemzell-Danielsson
and Meng, 2010). Although UPA is highly effective for EC (Glasier
et al., 2010; Cheng et al., 2012), the mechanisms underlying its action
are not completely understood. Its biological effects depend on the
stage of the menstrual cycle in which it is administered. Before the LH
peak, its primary mode of action is to inhibit or delay follicular rupture,
improving the effectiveness in pregnancy prevention compared with pre-
existing contraceptive methods (Brache et al., 2013). However, when
administered at or after the LH peak, UPA cannot prevent ovulation
(Brache et al., 2010). Considering that unprotected sexual intercourse
may occur at any time of the female menstrual cycle, it is important to
establish whether UPA can work for EC even when administered at or
after the LH peak. After ovulation, the oviduct constitutes an excellent
site for UPA action as it can interfere with gamete transport and
storage, fertilization or early embryo development. It was previously
reported that human spermatozoa exposed in vitro to UPA concentra-
tions similar to those found in the serum of emergency contraceptive
pill users (100–200 ng/ml) (Blithe et al., 2003) present no differences
in viability, protein tyrosine phosphorylation or spontaneous or follicular
fluid-induced acrosome reaction (Munuce et al., 2012). However, a
significant decrease in sperm DNA fragmentation was observed in the
presence of UPA, probably due to the capacity of this compound to
capture oxygen-free radicals (Munuce et al., 2013). Whereas these
results do not indicate a direct effect of UPA on sperm function,
recent reports have revealed that UPA inhibits ciliary beat and muscular
contraction of the human Fallopian tube in vitro (Li et al., 2014), opening
the possibility of post-ovulatory effects of UPA on gamete transport, fer-
tilization and/or embryo development.
Considering the unfeasibility of sperm transport and in vivo fertilization
studies in humans owing to ethical and technical limitations, the mouse
model represents a tool for exploring the potential effects of UPA on
these processes. In this regard, it has been shown that the administration
of UPA up to 8-h post-hCG (ovulation occurs 12-h post-hCG) inhibits
mouse ovulation (Nallasamy et al., 2013) indicating that female mice
respond to UPA in a similar way than humans. In view of this, the aim
of this work was to evaluate the potential of UPA to regulate in vitro
and in vivo mouse gamete interaction or embryo development.
Materials and Methods
Ethical approval
Approval for the study protocol was obtained from the Bioethics Committee
of IBYME-CONICET (no. CE010-Abril/2014) and the Institutional Review
Board of the School of Biochemical and Pharmaceutical Sciences, National
University of Rosario. Experiments involving animals were performed at
IBYME-CONICET in strict accordance with the Guide for Care and Use of
Laboratory Animals approved by the National Institutes of Health (NIH).
Animals and reagents
Adult (60–120 days old) male, immature (21–35 days old) and young adult
(60–120 days old) female hybrid (C57BL/6xBALB/c)F1 mice were used.
Animals were maintained with food and water ad libitum in a temperature-
controlled room (238C) with light:dark (12:12 h, lights on: 7:00 AM) cycle.
All reagents and chemicals were of molecular biology grade and were pur-
chased from Sigma-Aldrich Chemicals (St Louis, MO, USA), unless otherwise
specified. For in vitro experiments, a stock solution of UPA (1 mg/ml, HRA
Pharma, Paris, France) was prepared in ethanol and stored at 2208C until
use. Working solutions were further diluted on the day of the experiment
to obtain the range of UPA concentrations used.
Sperm capacitation
Mouse spermatozoa were recovered by incising the cauda epididymis in
300 ml capacitation medium (Fraser and Drury, 1975) supplemented with
0.3% (w/v) bovine serum albumin under paraffin oil (Ewe, Sanitas SA,
Buenos Aires, Argentina). Aliquots of the suspension were added to 300
ml fresh medium previously placed in tissue culture dishes containing UPA
(10–1000 ng/ml) or an equivalent volume of ethanol (control) to give a
final concentration of 1–10 × 106 cells/ml. These concentrations of UPA
were chosen from the pharmacokinetic data of the 30 mg oral tablet render-
ing a peak plasma concentration of UPA (bound and unbound) 1 h after in-
gestion of 176+89 ng/ml (Blithe et al., 2003; Snow et al., 2011). Sperm
suspensions were then incubated for 90 min under paraffin oil at 378C in
an atmosphere of 5% (v/v) CO2 in air.
Acrosome reaction assays
Mouse spermatozoa were incubated for 90 min in the presence of different
concentrations of UPA (10–1000 ng/ml) and then evaluated for both spon-
taneous and P-induced acrosome reaction. For induction of the acrosome
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reaction, P (15 mM final concentration) in dimethylsulfoxide was added to
spermatozoa for the last 15 min of incubation under capacitating conditions.
The acrosomal status was evaluated by Coomassie Brilliant Blue staining as
previously described (Busso et al., 2007). At least 400 spermatozoa were
evaluated in each treatment slide in a light microscope (×400) and the per-
centage of spermatozoa without an intact acrosome was calculated.
Sperm viability determination
Sperm viability was assessed by dye exclusion using 0.5% (v/v) Eosin Y and
the percentage of viable spermatozoa was calculated as the number of
spermatozoa that did not incorporate the dye divided by the total number
of spermatozoa counted in the light microscope (×400).
Egg collection and in vitro fertilization assays
In vitro fertilization was performed as previously described (Curia et al., 2013).
Briefly, 3–4 female mice per experiment were superovulated by an injection
(i.p.) of equine chorionic gonadotrophin (eCG; 5UI; Syntex, Argentina) 1 h
before the lights turned out, followed by the administration (i.p.) of human
chorionic gonadotrophin (hCG; 5UI) 48 h later. Egg–cumulus complexes
were collected from the oviducts 13–14 h after hCG administration and
pooled. When required, cumulus cells were removed by incubating the com-
plexes for 3 min in 0.3 mg/ml hyaluronidase (Type IV). Cumulus-intact eggs
or cumulus-free zona pellucida-intact eggs were inseminated with capaci-
tated spermatozoa (final concentration: 5–6 × 105 spermatozoa/ml) and
gametes were co-incubated for 5 h in the presence or absence of UPA
(10–1000 ng/ml) or ethanol at 378C in an atmosphere of 5% (v/v) CO2 in
air. Eggs were then transferred to fresh medium and 15 h later the number
of 2-cell embryos was recorded.
Effect of UPA on ovulation
UPAwasdissolved insesameoil andadministered i.p. at40 mg/kgbodyweight
at the same time as the hCG injection. Females injected with the same volume
of vehicle (100 ml) were used as controls. In both cases, eggs were collected
as described above 14 h after administration of hCG and counted.
In vivo fertilization assays
Estrous cycle stage of mature females was determined every morning by the
analysis of vaginal smears. Briefly, vaginal epithelial cell samples were col-
lected in 30 ml of PBS with a pipette, placed on glass slides and visualized.
The different stages are characterized by the proportion of the three cell
types, i.e. leukocytes, cornified and nucleated epithelial cells present in the
sample. In proestrous stage, there is a predominance of nucleated epithelial
cells (Caligioni, 2009). A pair of females in the proestrous stage were super-
ovulated and caged with proven male breeders 12 h after hCG administra-
tion. Forty minutes later, successful mating was confirmed by the presence
of a copulatory plug. One female mouse received an i.p. injection of
40 mg/kg UPA and the other one, sesame oil (vehicle) before or after
mating according to the experiment. This dose was chosen because it was
previously shown to be the most effective in preventing ovulation in mice
(Palanisamy et al., 2006; Nallasamy et al., 2013). Seven hours after confirm-
ation of mating, eggs were recovered from the oviducts, stained with 10 mg/
ml Hoechst 33342, mounted on slides and analysed in a Nikon Optiphot
microscope (Nikon, Tokyo, Japan) equipped with epifluorescence optics
(×250). Eggs presenting either decondensing sperm heads or pronuclei in
the cytoplasm were considered as fertilized.
Effect of UPA on in vitro mouse
preimplantation embryo development
Immature female mice (two per experiment) were superovulated (eCG: 4 h
before lights turned out, hCG: 6 h before lights turned out) and mated with
male mice of proven fertility. Effectiveness of mating was confirmed by iden-
tification of a copulatory plug. Twenty hours after hCG injection, zygotes
were recovered from the oviducts in KSOM medium (Erbach et al., 1994).
Embryos were transferred to 50 ml drops of fresh KSOM medium supple-
mented with 1000 ng/ml UPA or control at 378C in a 5% (v/v) CO2 atmos-
phere in air and incubated for 4 days. Embryo development was evaluated
daily in an inverted microscope (Nikon Eclipse TS100, Nikon) and the devel-
opmental stage of each embryo was determined.
Statistical analysis
Values are presented as mean+ standard error of the mean (SEM) from at
least three independent experiments. Statistical analyses were performed
by using the GraphPad Prism software (San Diego, CA, USA). Statistical sig-
nificance of the data was analysed with two-way analysis of variance with the
Bonferroni post-test for acrosome reaction and in vitro fertilization assays or
Student’s t-test for viability, ovulation, in vivo fertilization and embryo devel-
opment assays. In all cases, data were considered significantly different when
the P-value was ,0.05.
Results
To evaluate the effect of UPA on gamete interaction in vitro, mouse
spermatozoa were capacitated in the presence of different concentra-
tions of UPA (10–1000 ng/ml) and used to inseminate cumulus-intact
eggs in the presence or absence of UPA during gamete co-incubation.
Evaluation of sperm viability at the end of the capacitation period with
the maximum concentration of UPA (1000 ng/ml) showed no differ-
ences in this parameter compared with the controls (data not shown),
confirming the lack of toxicity of the drug on spermatozoa during capaci-
tation. No significant differences were observed in the percentage of eggs
fertilized at any of the concentrations and conditions tested (Fig. 1a).
Considering the beneficial effects that cumulus cells exert on spermato-
zoa (Yanagimachi, 1994), the ability of UPA-treated spermatozoa to
penetrate cumulus-free eggs was also analysed. No differences in the
percentage of fertilized eggs were observed when the maximum concen-
tration of UPA was present during sperm capacitation and/or gamete
co-incubation (Fig. 1b). Consistent with fertilization results, no differ-
ences in the percentage of spontaneous or P-induced acrosome reaction
were detected at any of the concentrations of UPA assessed (Fig. 1c).
Considering that the in vivo capacitation process is associated with
sperm transport within the female tract and sperm interaction with the
oviductal cells (Yanagimachi, 1994), we also evaluated whether UPA
could affect these events and, thus, in vivo fertilization. For this
purpose, a single dose of UPA (40 mg/kg body weight) or vehicle
(control) was administered to superovulated females shortly before or
after mating, and the percentage of penetrated eggs was evaluated. In
parallel, to confirm the inhibitory effect of UPA on ovulation, a group
of females received UPA together with the hCG injection, and the
number of ovulated eggs was counted. Results revealed that whereas
the administration of UPA together with hCG caused a significant de-
crease in the number of eggs recovered from the ampulla compared
with controls (Fig. 2a), its administration before or after mating produced
no differences in either the total number of ovulated eggs (Fig. 2b) or the
percentage of in vivo fertilized eggs (Fig. 2c).
Additionally, to determine whether UPA impairs mouse preimplanta-
tion embryo development, zygotes were cultured in the presence
of 1000 ng/ml UPA and the progression of development was monitored
daily. No significant differences in either the percentage of developed
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embryos (percentage of blastocysts, control: 99+1 versus UPA: 98+
3) or the kinetics of development were observed between embryos cul-
tured in the presence or absence of UPA (Fig. 3).
Discussion
The emergency contraceptive pill is becoming more commonly used
worldwide. In the recent years, UPA, a selective PR modulator, has
been introduced in the market as a more efficient emergency contracep-
tive option than the existing methods (Glasier et al., 2010) by extending
the window of action to up to 5 days after intercourse compared with the
3 days obtained with the widely used levonorgestrel pill. Although it is
well established that the main action of UPA is to delay or to inhibit
follicular rupture (Brache et al., 2010), it is crucial to elucidate its
mechanisms of action for correct clinical recommendations and use.
This study shows that UPA, at concentrations similar to those reached
in the female serum after oral intake of the emergency contraceptive
pill, does not interfere with sperm transport through the female tract,
in vivo and in vitro gamete interaction or embryo development.
It has been clearly stated that P modulates different events in
spermatozoa that are associated with the capacitation process they
undergo while migrating through the female tract (Yanagimachi, 1994;
Baldi et al., 2009). Therefore, after unprotected intercourse and UPA
intake, spermatozoa may be exposed to the drug affecting their func-
tions. Furthermore, it has been proposed that muscular contractions
of the human oviduct at the time of ovulation could activate spermatozoa
stored in the isthmic region, increasing their chances of encountering the
egg, and that the tubal microenvironment plays an important role in
ensuring normal embryo development (Holt and Fazeli, 2010). In this
way, factors that modify tubal ciliary beating may interfere with con-
ception by affecting gametes or embryos, or by altering the timing of
embryo arrival at the uterine cavity. As it has been reported that UPA
in vitro modulates muscle contractions and ciliary beating in Fallopian
tube samples (Li et al., 2014), this might be one of the potential mechan-
isms of action of this drug. However, scarce information was available on
the effects of UPA on events occurring after ovulation and before im-
plantation. In this regard, our in vitro assays allowed the evaluation of
the effects of UPA on sperm capacitation, sperm-egg interaction and
embryo development whereas the in vivo approach also allowed the
analysis of its effects on sperm transport.
The cumulus cells that accompany the egg after ovulation continuously
synthesize and secrete P that modulates sperm function (Baldi et al.,
2009). In this regard, the presence of UPA did not affect in vitro fertiliza-
tion when cumulus–egg complexes were used supporting the view that
both hyperactivation and acrosome reaction occurred normally in
UPA-incubated spermatozoa. Furthermore, no effect of UPA was ob-
served on the P-induced acrosome reaction. Altogether, these results
suggest that the interaction of P with its receptor/s in spermatozoa is
not antagonized by UPA at the tested concentrations. Although it has
been shown that UPA blocks the two isoforms of the genomic PR in
other cellular systems (Attardi et al., 2004), this inhibitory mechanism
is unlikely to occur in spermatozoa which are transcriptionally inert
cells. A non-genomic plasma membrane PR, probably involved in the in-
duction of the acrosome reaction, has been found in the acrosomal
region of sperm from several species (Contreras and Llanos, 2001;
Wu et al., 2005, 2006). The lack of effect of UPA on the P-induced acro-
some reaction in mouse is consistent with previous observations
Figure 1 Effect of UPA on sperm fertilizing ability in vitro. Mouse
spermatozoa were capacitated for 90 min in the presence of different
concentrations of UPA (cap, 0–1000 ng/ml) and used to inseminate
cumulus-intact (a) or cumulus-free eggs (b) in the presence or
absence of UPA during gamete co-incubation (co-incub). The number
of 2-cell embryos was scored 20 h later. The values are presented as
mean+ SEM of 5 (a) or 3 (b) independent experiments. (c) Spontan-
eous and progesterone (15 mM)-induced acrosome reaction were eval-
uated by staining spermatozoa with Coomassie Brilliant Blue. The values
are presented as mean+ SEM of 8 independent experiments. Bars with
different letters are significantly different, P , 0.05.
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showing that UPA does not prevent the occurrence of the follicular
fluid-induced acrosome reaction in human sperm (Munuce et al.,
2012). A recent study shows an inhibitory effect of UPA on P-induced
acrosome reaction in human sperm (Ko et al., 2014); however, this inhib-
ition was only observed at drug concentrations higher than those present
in the sera of UPA users (Blithe et al., 2003; Snow et al., 2011). Recent
reports have shown that P modulates in human spermatozoa the activity
of CatSper (Lishko et al., 2011; Strunker et al., 2011), a key Ca2+ channel
localized in the sperm flagellum essential for hyperactivation and male
fertility (Ren et al., 2001; Smith et al., 2013). However, as mouse
CatSper is not regulated by P (Lishko et al., 2011), further experiments
with human spermatozoa will be required to evaluate the potential
effects of UPA on CatSper-mediated events.
In vitro fertilization experiments were also performed with cumulus-
free eggs, a more restricted condition in which deficiencies in sperm
fertilizing ability can be more clearly evidenced (Nishimura et al., 2004;
Da Ros et al., 2008). In addition, under this condition P is not present
during sperm capacitation or gamete interaction. In spite of this, no dif-
ferences in the percentage of fertilized eggs were observed between
groups, supporting the non-interference of UPA with sperm-egg inter-
action. From these observations, it can be postulated that sperm
plasma membrane PRs would not be modulated by UPA.
Considering the unfeasibility of in vivo studies in humans, we designed
an in vivo fertilization protocol using the mouse as an experimental
model. The decrease in the number of ovulated eggs recovered from
the ampulla of females injected with UPA at the moment of the hCG
injection confirmed that the administration route and dose of UPA
chosen in our studies were effective. The inhibition of ovulation
observed however was lower than that previously reported (Nalla-
samy et al., 2013). This difference could be due to the fact that in the
previous study the authors used immature females and longer times
to confirm ovulation, while our studies involved the use of adult
females and checking times closer to ovulation, resembling the situ-
ation faced during EC. When UPA was injected just before or after
mating, no effect on the number of eggs present in the oviduct was
observed, confirming that the efficacy of UPA as an antiovulatory
agent declines markedly when administered after the LH/hCG peak
(Brache et al., 2013). Our results constitute the first in vivo evidence
showing that the administration of UPA to females after mating does
not affect sperm transport and fertilization. The finding that injection
of UPA just before mating did not produce a decrease in fertilization
indicates that the rapid transport of spermatozoa described both in
mouse and humans (Suarez, 2006) is also unaffected by UPA. Although
the ciliary beating and muscle contraction inhibitions produced in vitro
Figure 2 Effect of UPA on sperm fertilizing ability in vivo. (a) Female
mice were superovulated by injection of eCG followed by the adminis-
tration of hCG 48 h later. Vehicle (sesame oil) or UPA (40 mg/kg) was
administered at the same time as hCG, and the number of ovulated eggs
was counted 14 h later. *P , 0.05. (b and c) Superovulated females
were caged 12 h post-hCG with males of proven fertility for 40 min.
Vehicle or UPA was injected before or after mating. Seven hours after
mating was confirmed, the number of total eggs (b) and the percentage
of fertilized eggs (c) were determined. The values are presented as
mean+ SEM of at least 5 independent experiments.
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by UPA have been proposed as an additional mechanism for its
contraceptive action (Li et al., 2014), our in vivo results showing high
levels of fertilized eggs in females treated with UPA do not support
this possibility.
Our in vitro experiments showed the lack of effect of UPA on embryo
development as judged by the similar cleavage rate and percentage
of blastocysts obtained in the UPA-treated and control groups. These
results are similar to those obtained with levonorgestrel (Munuce
et al., 2005) but different from those showing that mifepristone,
another EC method used in several countries (Benagiano et al., 2014),
retards in vivo and in vitro development of mouse embryos (Roblero
et al., 1987; Yang and Wu, 1990), supporting that the mechanism of
action of mifepristone might be different from that of UPA and levonor-
gestrel. It has been shown that UPA has post-coital antifertility effect
when given orally to rats during the implantation day (Reel et al.,
1998). In this regard, our observations, together with a recent report
showing that UPA does not affect human embryo attachment to endo-
metrial constructs in vitro (Berger et al., 2015), support the idea that
UPA would not affect embryo development or its interaction with the
endometrium in the dosage used for EC. Nevertheless, the possibility
that UPA affects embryo transport to the implantation site cannot be
excluded. Taking into account that the proportion of time the fertilized
eggs remain in the ampulla and the ithsmus differs between human
and mouse (Croxatto, 2002), another experimental model should be
used to explore this possibility.
Altogether, our results provide additional information on the mechan-
ism of action of UPA with potential clinical implications as they show that
a direct action of UPA on sperm function or transport would be of low
significance. These new findings improve our knowledge on the mechan-
ism of action of UPAand could contribute to increase its acceptability and
proper use.
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